OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbiome and metabolic response in non-alcoholic fatty liver disease
Asmita Madatali Abuwani, Shweta Priyadarshini Dash, Raja Ganesan, et al.
Clinica Chimica Acta (2021) Vol. 523, pp. 304-314
Closed Access | Times Cited: 13
Asmita Madatali Abuwani, Shweta Priyadarshini Dash, Raja Ganesan, et al.
Clinica Chimica Acta (2021) Vol. 523, pp. 304-314
Closed Access | Times Cited: 13
Showing 13 citing articles:
The interplay between oral microbiota, gut microbiota and systematic diseases
Xiujun Tan, Yizhong Wang, Ting Gong
Journal of Oral Microbiology (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 44
Xiujun Tan, Yizhong Wang, Ting Gong
Journal of Oral Microbiology (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 44
Diagnosis of liver disorder
Prasann Kumar, Padmanabh Dwivedi
Elsevier eBooks (2025), pp. 199-224
Closed Access
Prasann Kumar, Padmanabh Dwivedi
Elsevier eBooks (2025), pp. 199-224
Closed Access
Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis
Rongrong Wu, Duorui Nie, Fei He, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Rongrong Wu, Duorui Nie, Fei He, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
A critical review of microbiome-derived metabolic functions and translational research in liver diseases
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Phenolamide extract of apricot bee pollen alleviates glucolipid metabolic disorders and modulates the gut microbiota and metabolites in high-fat diet-induced obese mice
Xingxing Zhang, Xin Wu, Gengsheng Xiao, et al.
Food & Function (2023) Vol. 14, Iss. 10, pp. 4662-4680
Closed Access | Times Cited: 14
Xingxing Zhang, Xin Wu, Gengsheng Xiao, et al.
Food & Function (2023) Vol. 14, Iss. 10, pp. 4662-4680
Closed Access | Times Cited: 14
The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
Cengiz Callender, Ilias Attaye, Max Nieuwdorp
Metabolites (2022) Vol. 12, Iss. 1, pp. 65-65
Open Access | Times Cited: 20
Cengiz Callender, Ilias Attaye, Max Nieuwdorp
Metabolites (2022) Vol. 12, Iss. 1, pp. 65-65
Open Access | Times Cited: 20
Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
Sukrit Kanchanasurakit, Chayanis Kositamongkol, Kamonnat Lanoi, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 17
Sukrit Kanchanasurakit, Chayanis Kositamongkol, Kamonnat Lanoi, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 17
Role of Intestinal Microbes in Chronic Liver Diseases
Mengyi Xu, Kangkang Luo, Junjie Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12661-12661
Open Access | Times Cited: 17
Mengyi Xu, Kangkang Luo, Junjie Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12661-12661
Open Access | Times Cited: 17
Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine
Livianna Carrieri, Alberto R. Osella, Fausto Ciccacci, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1184-1184
Open Access | Times Cited: 11
Livianna Carrieri, Alberto R. Osella, Fausto Ciccacci, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1184-1184
Open Access | Times Cited: 11
LC-IMS-HRMS for identification of biomarkers in untargeted metabolomics: The effects of pterostilbene and resveratrol consumption in liver steatosis, animal model
Leticia Lacalle-Bergeron, David Izquierdo-Sandoval, Alfredo Fernández‐Quintela, et al.
Food Research International (2023) Vol. 165, pp. 112376-112376
Open Access | Times Cited: 6
Leticia Lacalle-Bergeron, David Izquierdo-Sandoval, Alfredo Fernández‐Quintela, et al.
Food Research International (2023) Vol. 165, pp. 112376-112376
Open Access | Times Cited: 6
Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial
Haifeng Lu, Xiaofei Zhu, Lingyun Wu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
Haifeng Lu, Xiaofei Zhu, Lingyun Wu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
Microbiome-Targeted Therapies: Enhancing Resilience in Metabolic Disorders
Sara Janiad, Kanwal Rehman
(2024), pp. 401-436
Closed Access
Sara Janiad, Kanwal Rehman
(2024), pp. 401-436
Closed Access
Mass spectometry based untargeted metabolomics in food and health area
María Leticia Lacalle Bergeron
(2022)
Open Access
María Leticia Lacalle Bergeron
(2022)
Open Access
